News

  1. 12/04/2014 Catalent & SELLAS Sign Exclusive Agreement For Therapeutic Reprofiling

  2. 12/02/2014 Catalent and Valerion Collaborate on New Treatments For Orphan Genetic Disorders

  3. 11/13/2014 Catalent Acquires Micron Technologies

  4. 11/03/2014 Catalent Expands Highly Potent And Cytotoxic Clinical Packaging Capabilities

  5. 10/30/2014 Latest Developments in Bioavailability, Drug Delivery & More Presented At AAPS

  6. 10/28/2014 Catalent Appoints Mark Bisset as President, Catalent Asia Pacific

  7. 10/21/2014 ADC Generation Using SMARTag™ Technology Presented At World ADC Congress

  8. 10/14/2014 Catalent Appoints Senior Vice President And General Counsel

  9. 10/08/2014 Catalent and Redwood Bioscience Win Inaugural ‘Innovation In Partnering’ Award

  10. 10/06/2014 Catalent Applied Drug Delivery Institute Collaborates With Lung Cancer Alliance

  11. 10/02/2014 Catalent Acquires Redwood Bioscience Inc. and the SMARTag™ Technology Platform

  12. 09/30/2014 Catalent Announced Full Agenda for 25th Annual CPhI Worldwide Conference

  13. 09/25/2014 Catalent Announces Two Senior Executive Appointments to Its Development Business

  14. 09/24/2014 Catalent and Cingulate Therapeutics Sign Exclusive Agreement

  15. 09/17/2014 New OptiPact™ Technology Introduced By Catalent

  16. 09/15/2014 Best Practices In Risk Mitigation Presented By Catalent At Internal Audit Summit

  17. 09/08/2014 Bioavailability Symposium Announced by Catalent Applied Drug Delivery Institute

  18. 09/04/2014 Catalent Announces Two Senior Appointments To Its Biologics Business

  19. 08/27/2014 Catalent & Minomic Collaborate To Bring New Prostate Cancer Treatment To Market

  20. 08/14/2014 Catalent Confirms Appointment of Two Healthcare Executives to Board of Directors

  21. 07/31/2014 Catalent, Inc. Announces Pricing of Its Initial Public Offering

  22. 07/29/2014 Catalent Expert to Present at Japan Society of Drug Delivery Systems

  23. 07/09/2014 Nine Catalent Experts to Present on Industry Challenges & Drug Delivery at CRS

  24. 07/01/2014 Catalent Marks 40 Years in Japan with New Investments and Country Leader

  25. 06/26/2014 FDA Invites Catalent to Present on New Drug Delivery Technologies

  26. 06/24/2014 New Study: Decreased Mortality & Better Tolerability of ADC w/ SMARTag Platform

  27. 06/19/2014 Latest Developments in ADC Presented by Catalent and Redwood Biosciences at BIO

  28. 06/16/2014 Creating A Culture of Operational Excellence Presented at European Summit

  29. 06/11/2014 Annual Competition Recognizes Talent In Graduate Pharmaceutical Programs

  30. 05/07/2014 Innovation Symposium Announced By Catalent Applied Drug Delivery Institute

  31. 05/02/2014 Oral Drug Delivery Formulation Techniques Showcased At Recent Event

  32. 04/30/2014 Continual Performance Monitoring Of Potency Assays Presented At IBC Conference

  33. 04/02/2014 New Drug Delivery Technologies to be Presented by Catalent Experts at ICSE Japan

  34. 03/24/2014 Catalent Increases Stake In Redwood Bioscience

  35. 03/17/2014 Catalent Celebrates 80 Years of Softgel Innovation at Interphex

  36. 03/11/2014 Catalent Launches ADVASEPTTM For Glass-Free Delivery Of Injectable Drugs

  37. 03/10/2014 Use Of QbD To Mitigate Risk In Aseptic Fill/Finish Presented At PDA Conf

  38. 03/06/2014 Catalent Announces Agreement For One Of The First Regenerative Therapies

  39. 02/26/2014 Catalent Announces Two Senior Appointments To Expand Biologics Business

  40. 02/17/2014 Catalent and Redwood Bioscience to Present on Next Generation Drug Conjugates

  41. 02/10/2014 Improved Drug Delivery in Animal Health Presented by Catalent Experts

  42. 02/06/2014 Leading Industry & Academic Experts to Discuss Drug Delivery Technologies

  43. 02/04/2014 Catalent Demonstrates Process Excellence During PEX Week

  44. 01/24/2014 Catalent Files Registration Statement For Initial Public Offering

  45. 01/24/2014 New Technologies and QbD Concepts to be Discussed at Forthcoming Events

  46. 01/23/2014 3rd Annual Global Academic Competition for Life Science Leaders of Tommorrow

  47. 01/07/2014 Catalent and Adamas Pharmaceuticals Enter Into Phase III Manufacturing Agreement